Bruush Oral Price To Sales vs. EBITDA

BRSHDelisted Stock  USD 0.0005  0.0001  16.67%   
Taking into consideration Bruush Oral's profitability measurements, Bruush Oral Care may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Bruush Oral's ability to earn profits and add value for shareholders.
For Bruush Oral profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bruush Oral to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bruush Oral Care utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bruush Oral's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bruush Oral Care over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Please note, there is a significant difference between Bruush Oral's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bruush Oral is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bruush Oral's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bruush Oral Care EBITDA vs. Price To Sales Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Bruush Oral's current stock value. Our valuation model uses many indicators to compare Bruush Oral value to that of its competitors to determine the firm's financial worth.
Bruush Oral Care is number one stock in price to sales category among its peers. It is rated below average in ebitda category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bruush Oral's earnings, one of the primary drivers of an investment's value.

Bruush EBITDA vs. Price To Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Bruush Oral

P/S

 = 

MV Per Share

Revenue Per Share

 = 
2.97 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Bruush Oral

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(10.49 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Bruush EBITDA Comparison

Bruush Oral is currently under evaluation in ebitda category among its peers.

Bruush Oral Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Bruush Oral, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bruush Oral will eventually generate negative long term returns. The profitability progress is the general direction of Bruush Oral's change in net profit over the period of time. It can combine multiple indicators of Bruush Oral, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Bruush Oral Care Inc., an oral care company, manufactures and sells electric toothbrushes in the United States and Canada. Bruush Oral Care Inc. was incorporated in 2017 and is headquartered in Toronto, Canada. Bruush Oral operates under Household Personal Products classification in the United States and is traded on NASDAQ Exchange.

Bruush Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Bruush Oral. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bruush Oral position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bruush Oral's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Bruush Oral without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module

Use Investing Themes to Complement your Bruush Oral position

In addition to having Bruush Oral in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Israel Wall Street Thematic Idea Now

Israel Wall Street
Israel Wall Street Theme
Cross-sector collection of best publicly traded Israel entities that are expected to continue growing. The Israel Wall Street theme has 71 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Israel Wall Street Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Consideration for investing in Bruush Stock

If you are still planning to invest in Bruush Oral Care check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bruush Oral's history and understand the potential risks before investing.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.